Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Genocea Biosciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +4 vs. Q1 2021
- Shares held
- 33.9M
- +2.09M (+6.6%) vs. Q1 2021
- Total value
- $79.4M
- −$6.89M (−8.0%) vs. Q1 2021
- New holders
- 12
- 11 more added
- Sold out
- 8
- 7 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 10,376,936 | $24.3M | 0.32% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $11.9M | 0.21% | 00.0% | Unchanged |
| BVF Inc | 4,012,404 | $9.39M | 0.35% | 00.0% | Unchanged |
| Commodore Capital LP | 2,929,447 | $6.86M | 2.39% | +57,823+2.0% | Added |
| Point72 Asset Management, L.P. | 2,500,000 | $5.85M | 0.03% | +2,500,000 | New |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $4.62M | 0.70% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,872,236 | $4.38M | 0.00% | +41,450+2.3% | Added |
| Vanguard Group Inc | 1,538,463 | $3.60M | 0.00% | −78,581−4.9% | Reduced |
| Boxer Capital, LLC | 1,134,453 | $2.65M | 0.09% | 00.0% | Unchanged |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $878.0K | 2.94% | 00.0% | Unchanged |
| Millennium Management LLC | 286,041 | $669.0K | 0.00% | +24,185+9.2% | Added |
| Two Sigma Advisers, LP | 248,477 | $581.0K | 0.00% | −156,000−38.6% | Reduced |
| HighTower Advisors, LLC | 212,270 | $496.0K | 0.00% | +2,210+1.1% | Added |
| Ikarian Capital, LLC | 200,000 | $468.0K | 0.08% | +121,233+153.9% | Added |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $462.0K | 0.74% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 179,714 | $420.0K | 0.00% | +6,307+3.6% | Added |
| BlackRock Inc. | 178,972 | $419.0K | 0.00% | +35,685+24.9% | Added |
| Two Sigma Investments, LP | 154,447 | $361.0K | 0.00% | −234,562−60.3% | Reduced |
| Diametric Capital, LP | 69,977 | $164.0K | 0.12% | +69,977 | New |
| Bank of America Corp | 57,186 | $134.0K | 0.00% | −14,601−20.3% | Reduced |
| Prelude Capital Management, LLC | 43,643 | $102.0K | 0.01% | +43,643 | New |
| Northern Trust Corp | 39,882 | $93.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 23,095 | $54.0K | 0.00% | +23,095 | New |
| Commonwealth Equity Services, LLC | 20,705 | $48.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19,675 | $46.0K | 0.00% | +14,760+300.3% | Added |
| State Street Corp | 19,684 | $46.0K | 0.00% | +19,684 | New |
| UBS Oconnor LLC | 19,170 | $45.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16,504 | $39.0K | 0.00% | +10,957+197.5% | Added |
| Bank of New York Mellon Corp | 16,305 | $38.0K | 0.00% | −2,535−13.5% | Reduced |
| Virtu Financial LLC | 15,625 | $37.0K | 0.00% | +15,625 | New |
| Personal Capital Advisors Corp | 15,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $35.0K | 0.01% | 00.0% | Unchanged |
| First Republic Investment Management, Inc. | 12,285 | $29.0K | 0.00% | +12,285 | New |
| Capital Asset Advisory Services LLC | 11,766 | $28.0K | 0.00% | +11,766 | New |
| ExodusPoint Capital Management, LP | 11,131 | $26.0K | 0.00% | −100−0.9% | Reduced |
| Wells Fargo & Company | 9,532 | $22.0K | 0.00% | +20.0% | Added |
| Tower Research Capital LLC (TRC) | 8,574 | $20.0K | 0.00% | −328−3.7% | Reduced |
| Pinz Capital Management, LP | 7,200 | $17.0K | 0.01% | +7,200 | New |
| ACT Capital Management, LLC | 5,000 | $12.0K | 0.01% | +5,000 | New |
| Vectors Research Management, LLC | 5,000 | $12.0K | 0.00% | +5,000 | New |
| UBS Group AG | 3,834 | $9.00K | 0.00% | +3,834 | New |
| First Manhattan Co | 2,500 | $5.00K | 0.00% | +100+4.2% | Added |
| Artemis Wealth Advisors, LLC | 1,137 | $3.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −190,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −128,203−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −80,876−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,659−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −18,578−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −13,616−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,763−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |